Keyi Xu

578 citations
14 papers · 405 indexed · h-index 7
Topics
HIV Research and Treatment (7 papers)HIV/AIDS Research and Interventions (7 papers)HIV, Drug Use, Sexual Risk (3 papers)

In The Last Decade

Keyi Xu

14 papers receiving 393 citations

Peers

Keyi Xu
Comparison fields: 5 of 64
  • Infectious Diseases 290
  • General Health Professions 202
  • Epidemiology 100
  • Family Practice 73
  • Virology 71
Replace Félix Carpio with:
Félix Carpio United States
Cáritas Relva Basso Brazil
Ramsey A. Lyimo Netherlands
Laurie Andrews United States
Dale Stratford United States
Rene Macy United States
Adolfo Caldas United States
Heather Madray United States
Marcelo Araújo de Freitas Brazil
Emily E. Pisarski United States
Keyi Xu relative to Félix Carpio United States Félix Carpio's profile →
Citations per field
00.5×2.6×
Félix Carpio · 1×
Citations per year

Countries citing papers authored by Keyi Xu

Since Specialization
Citations

This map shows the geographic impact of Keyi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyi Xu more than expected).

Fields of papers citing papers by Keyi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyi Xu. The network helps show where Keyi Xu may publish in the future.

Co-authorship network of co-authors of Keyi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Keyi Xu. A scholar is included among the top collaborators of Keyi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyi Xu. Keyi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 5
2 6
3 3
4 3
5 109
6 2
7 46
8 3
9 88
10 36
11 62
12
[Epidemiologic study and HLA analysis of highly exposed to HIV but persistently seronegative subjects (HEPS) in commercial blood donors in China].
3
13 15
14 24

About Keyi Xu

Keyi Xu is a scholar working on Virology, Family Practice and Infectious Diseases, having authored 14 papers that have together received 405 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (7 papers) and HIV, Drug Use, Sexual Risk (3 papers). The work is most often cited by research in Family Practice (73 citations), Infectious Diseases (290 citations) and Virology (71 citations). Keyi Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mary Bachman DeSilva, Christopher Gill, Lora Sabin, Ira B. Wilson, Davidson H. Hamer, Tao Li, Jianbo Zhang, Taryn Vian, Wubin Xie and David R. Bangsberg. Their work appears in journals such as PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026